Garde Capital Has Lifted By $679,120 Its Johnson & Johnson Com (JNJ) Stake; 3 Analysts Bullish BCE Inc. (TSE:BCE)

March 22, 2018 - By David King

Among 9 analysts covering BCE Inc. (TSE:BCE), 3 have Buy rating, 1 Sell and 5 Hold. Therefore 33% are positive. BCE Inc. had 34 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Outperform” rating by RBC Capital Markets on Friday, April 29. The firm has “Underperform” rating by Macquarie Research given on Tuesday, October 27. RBC Capital Markets maintained BCE Inc. (TSE:BCE) on Thursday, June 9 with “Outperform” rating. The stock has “Outperform” rating by RBC Capital Markets on Friday, August 7. On Monday, August 3 the stock rating was maintained by Barclays Capital with “Overweight”. Barclays Capital maintained the stock with “Outperform” rating in Friday, August 28 report. As per Friday, August 7, the company rating was maintained by Scotia Capital. The company was maintained on Friday, February 5 by RBC Capital Markets. Desjardins Securities downgraded BCE Inc. (TSE:BCE) on Friday, July 24 to “Hold” rating. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, December 17. See BCE Inc. (TSE:BCE) latest ratings:

Garde Capital Inc increased Johnson & Johnson Com (JNJ) stake by 276.4% reported in 2017Q3 SEC filing. Garde Capital Inc acquired 5,224 shares as Johnson & Johnson Com (JNJ)’s stock rose 6.85%. The Garde Capital Inc holds 7,114 shares with $925,000 value, up from 1,890 last quarter. Johnson & Johnson Com now has $341.82B valuation. The stock decreased 2.87% or $3.77 during the last trading session, reaching $127.42. About 5.91 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since March 22, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity. Stoffels Paulus sold $20.17M worth of Johnson & Johnson (NYSE:JNJ) on Thursday, February 15.

Investors sentiment increased to 0.87 in Q3 2017. Its up 0.04, from 0.83 in 2017Q2. It is positive, as 45 investors sold JNJ shares while 871 reduced holdings. 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Guardian Cap Advsrs LP invested in 91,324 shares. Hemenway Trust Ltd Liability invested in 3.34% or 123,000 shares. Somerville Kurt F stated it has 162,071 shares or 4.2% of all its holdings. Carret Asset Limited Liability Corporation stated it has 129,774 shares or 2.72% of all its holdings. Schnieders Management has 56,822 shares. Forward Ltd Liability Corp holds 0.15% or 10,055 shares in its portfolio. Confluence Inv Mgmt Ltd has 1.02 million shares. Blb&B Advisors Ltd Liability reported 2.56% of its portfolio in Johnson & Johnson (NYSE:JNJ). Parkside Bancshares And Tru holds 19,220 shares. Logan Cap Management invested in 35,108 shares. First Light Asset Mgmt Llc has 2,183 shares. Aviance Partners Lc reported 0.98% in Johnson & Johnson (NYSE:JNJ). Graybill Bartz And Assocs Ltd holds 25,561 shares. Milestone Group, Colorado-based fund reported 13,943 shares. California State Teachers Retirement Systems stated it has 1.36% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. On Wednesday, August 2 the stock rating was maintained by BTIG Research with “Sell”. UBS maintained it with “Buy” rating and $14800 target in Wednesday, July 19 report. The firm has “Sell” rating by BTIG Research given on Tuesday, January 23. UBS maintained the stock with “Buy” rating in Wednesday, October 19 report. The firm earned “Buy” rating on Thursday, October 19 by Credit Suisse. The firm has “Neutral” rating by Goldman Sachs given on Monday, March 14. The rating was maintained by Jefferies on Tuesday, August 15 with “Hold”. The firm has “Hold” rating given on Wednesday, October 18 by Stifel Nicolaus. Goldman Sachs maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 20 with “Neutral” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Outperform” rating given on Wednesday, October 7 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts